DIALYSIS
Clinical trials for DIALYSIS explained in plain language.
Never miss a new study
Get alerted when new DIALYSIS trials appear
Sign up with your email to follow new studies for DIALYSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Robot pump aims to tame blood sugar in High-Risk dialysis patients
Disease control CompletedThis study tested a new automated insulin delivery system for people with diabetes who also have advanced kidney disease or are on dialysis. The goal was to see if this 'artificial pancreas' system could better control blood sugar levels compared to usual care. Fifteen participan…
Matched conditions: DIALYSIS
Phase: NA • Sponsor: Steno Diabetes Center Copenhagen • Aim: Disease control
Last updated Apr 02, 2026 00:41 UTC
-
Could a change in dialysis routine save limbs?
Disease control CompletedThis study tested whether a different dialysis schedule could help protect the legs and feet of people with kidney failure. It compared the standard schedule (4 hours, 3 times a week) with a daily schedule (2 hours, 6 times a week) in 60 patients. The goal was to see which method…
Matched conditions: DIALYSIS
Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Apr 02, 2026 00:40 UTC
-
New drug aims to tame dangerous mineral in kidney patients
Disease control CompletedThis study tested a new drug called AP301 to see if it works as well as or better than a standard medication (sevelamer) at controlling high phosphorus levels in the blood of people on long-term dialysis. It involved 474 Chinese adults with chronic kidney disease who were receivi…
Matched conditions: DIALYSIS
Phase: PHASE3 • Sponsor: Alebund Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Year-long safety check for kidney disease phosphorus drug
Disease control CompletedThis study tested the long-term safety of MCI-196, a medication that helps control high phosphorus levels in people with advanced kidney disease who are on dialysis. The research followed 632 patients for up to one year to monitor how well they tolerated the medication and whethe…
Matched conditions: DIALYSIS
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug aims to tame dual threat for dialysis patients
Disease control CompletedThis large, completed Phase 3 trial tested whether the drug MCI-196 could help control two common problems in people with kidney failure on dialysis: high phosphorus and high 'bad' cholesterol. The study involved 642 stable dialysis patients who were randomly assigned to receive …
Matched conditions: DIALYSIS
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for dialysis patients struggling with dangerous mineral levels
Disease control CompletedThis study tested whether a drug called MCI-196 could safely and effectively control high phosphorus levels in the blood of adults with kidney failure who are on dialysis. After a 12-week period where all participants received the drug, some were randomly switched to a placebo (d…
Matched conditions: DIALYSIS
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New drug tested for Long-Term safety in dialysis patients
Disease control CompletedThis study tested the long-term safety and effectiveness of a drug called MCI-196 for people on dialysis who have high phosphate levels in their blood. It involved 116 adult patients on stable dialysis treatment. The main goal was to see how safe the drug was over a year, while a…
Matched conditions: DIALYSIS
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Doctors try new conversation tool to help kidney patients plan their care
Symptom relief CompletedThis study tested whether a special communication tool called 'Best Case/Worst Case' helps doctors have better conversations with older patients who have severe, permanent kidney failure. The tool helps doctors and patients talk about future care options, quality of life, and end…
Matched conditions: DIALYSIS
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Mar 30, 2026 14:35 UTC
-
Researchers investigate why patients need emergency kidney treatment
Knowledge-focused CompletedThis study aimed to understand why some patients on Reunion Island need to start dialysis as an emergency, rather than through planned care. Researchers looked at 233 adults who began dialysis treatment on the island, examining their medical and social situations. The goal was to…
Matched conditions: DIALYSIS
Sponsor: Centre Hospitalier Universitaire de la Réunion • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:25 UTC
-
Dialysis type may affect bone health, study finds
Knowledge-focused CompletedThis study compared bone and mineral health in 167 adults with chronic kidney disease who were receiving either hemodialysis or peritoneal dialysis. Researchers analyzed patients' existing blood test results to understand how the two dialysis methods might differently affect bone…
Matched conditions: DIALYSIS
Sponsor: Çanakkale Onsekiz Mart University • Aim: Knowledge-focused
Last updated Mar 13, 2026 15:06 UTC